Related Experiment Video
Updated: Jul 9, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Multiple biochemical similarities between infectious and non-infectious aggregates of a prion protein carrying an
Emiliano Biasini1, Andrea Z Medrano, Stefano Thellung
1Department of Cell Biology and Physiology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Abstract:
A nine-octapeptide insertion in the prion protein (PrP) gene is associated with an inherited form of human prion disease. Transgenic (Tg) mice that express the mouse homolog of this mutation (designated PG14) spontaneously accumulate in their brains an insoluble and weakly protease-resistant form of the mutant protein. This form (designated PG14(Spon)) is highly neurotoxic, but is not infectious in animal bioassays. In contrast, when Tg(PG14) mice are inoculated with the Rocky Mountain Laboratory (RML) strain of prions, they accumulate a different form of PG14 PrP (designated PG14(RML)) that is highly protease resistant and infectious in animal transmission experiments. We have been interested in characterizing the molecular properties of PG14(Spon) and PG14(RML), with a view to identifying features that determine two, apparently distinct properties of PrP aggregates: their infectivity and their pathogenicity. In this paper, we have subjected PG14(Spon) and PG14(RML) to a panel of assays commonly used to distinguish infectious PrP (PrP(Sc)) from cellular PrP (PrP(C)), including immobilized metal affinity chromatography, precipitation with sodium phosphotungstate, and immunoprecipitation with PrP(C)- and PrP(Sc)-specific antibodies. Surprisingly, we found that aggregates of PG14(Spon) and PG14(RML) behave identically to each other, and to authentic PrP(Sc), in each of these biochemical assays. PG14(Spon) however, in contrast to PG14(RML) and PrP(Sc), was unable to seed the misfolding of PrP(C) in an in vitro protein misfolding cyclic amplification reaction. Collectively, these results suggest that infectious and non-infectious aggregates of PrP share common structural features accounting for their toxicity, and that self-propagation of PrP involves more subtle molecular differences.
Insights
Inherited prion disease mutations create toxic, non-infectious protein aggregates (PG14(Spon)) and infectious aggregates (PG14(RML)). Both share biochemical properties with PrP(Sc), but only PG14(RML) propagates, suggesting subtle differences drive prion infectivity.
Area of Science:
- Neuroscience
- Biochemistry
- Genetics
Background:
- A nine-octapeptide insertion in the prion protein (PrP) gene causes inherited human prion disease.
- Transgenic mice expressing the PG14 mutation develop neurotoxic, non-infectious PG14(Spon) aggregates.
- Inoculation with prions generates infectious PG14(RML) aggregates in these mice.
Purpose of the Study:
- To characterize the molecular properties of PG14(Spon) and PG14(RML) aggregates.
- To identify features distinguishing prion infectivity and pathogenicity.
- To understand the molecular basis of PrP aggregate self-propagation.
Main Methods:
- Subjecting PG14(Spon) and PG14(RML) to biochemical assays (IMAC, PTA precipitation, immunoprecipitation).
- Comparing aggregate behavior to authentic PrP(Sc) and PrP(C).
- Assessing seeding ability in in vitro protein misfolding cyclic amplification (PMCA).
Main Results:
- PG14(Spon) and PG14(RML) aggregates exhibited identical biochemical properties to PrP(Sc).
- PG14(Spon) failed to seed PrP(C) misfolding in vitro, unlike PG14(RML) and PrP(Sc).
- This indicates non-infectious aggregates share structural features with infectious ones, but differ in propagation.
Conclusions:
- Infectious and non-infectious PrP aggregates share common structural determinants of toxicity.
- Prion self-propagation involves subtle molecular differences not captured by standard biochemical assays.
- Further research is needed to elucidate the precise mechanisms of prion propagation.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Subviral Agents
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...

